Legal Opinion
Mylan Laboratories, Inc. v. Leavitt
District Court, District of Columbia
Decided April 30, 2007No. Civil Action No.: 07-579 (RMU), Documents Nos. 44, 47, 48PublishedCited by 14 opinions
1Opinion of the Court
MEMORANDUM OPINION
URBINA, District Judge.
Denying Mylan’s Application for a Preliminary Injunction; Denying Apotex’s Motion for a Preliminary Injunction; Denying Teva’s Application for In-junctive Relief
I. INTRODUCTION
In this case, four generic drug manufacturers of the drug amlodipine besylate each take issue with various portions of an FDA decision concerning their rights to market and sell their generic version of the drug under the Hatch-Waxman Amendments to the Federal Food, Drug and Cosmetic Act (“FDCA”). Each manufacturer seeks to clear the regulatory hurdles so that it can sell its…
2Cases cited30 opinions
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- Califano v. SandersSupreme Court of the United States · 1977
- Mazurek v. ArmstrongSupreme Court of the United States · 1997
- Marsh v. Oregon Natural Resources CouncilSupreme Court of the United States · 1989
25 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- Converdyn v. MonizDistrict Court, District of Columbia · 2014
- ALLINA HEALTH SERVICES v. SebeliusDistrict Court, District of Columbia · 2010
- Mylan Pharmaceuticals, Inc. v. SebeliusDistrict Court, District of Columbia · 2012
- Apotex Inc. v. U.S. Food & Drug AdministrationDistrict Court, District of Columbia · 2007
- Mylan Laboratories, Inc. v. LeavittDistrict Court, District of Columbia · 2007
9 more not listed; retrieve them via the Exa API.